NUCLEAR MEDICINE DEPARTMENT


dr. ISTVÁN PÉTER SINKOVICS

Head Physician, Head of Department

CV


Colleagues:

Head:
István Sinkovics, MD, PhD - CV


Melinda Téglás, MD
László Szám, engineer
Park Kyung-Jy, MD resident

Specialized assistants, isotope assistants, clerks:
Mészáros Ágnes
Márkusné Szalai Piroska
Czelba Ferencné
Kurcz Timea
Mészáros Mária
Bozsó Judit Antónia
Hoffman Lászlóné
Pap Katalin

Clinical activity

The Department of Nuclear Medicine has a diagnostic and a therapeutic unit.
In addition, admission, decontamination and care of patients with radiation injury also take place here.

Diagnostic (out-patient) unit of the Department of Nuclear Medicine

The Department performs in vivo examinations only. There is a hot isotope laboratory for the preparation of radiopharmaceuticals. A separate room is available for the injection of the radioactive material.
The Department has three gamma cameras:
MEDISO NUCLINE planar gamma camera
TOSHIBA SPECT one headed
MEDISO SPECT/CT

Diagnostic activity

About 4000 diagnostic scans in a year are performed.
Bone scintigraphy (whole body, SPECT, SPECT/CT)
Sentinel node examinations (breast cancer, melanoma)
Somatostatin receptor scintigraphy
MIBG scintigraphy
Pulmonary perfusion examinations (Renography)
Thyroid scintigraphy

Essential parameters of therapeutic activities

The inpatient department has 8 beds.
It consists of:
- Two one bed isolation ward and one with 2 beds, each with separate bathrooms. The wards have adequate radioprotection where high activity isotop therapy can be performed.
- One isolation ward with 4 beds also with a separate bathroom
In case of emergency, the in-patient department can be extended to 18 beds
On the average 500 patients per year are admitted to the department for thyroid cancer traetment. Patients with thyroid cancer not only from the capital, but from the whole country are admitted for radioiodine therapy, as we are the most important department in Hungary specialized on this therapy.
The number of 131I-MIBG treatments for neuroendocrin tumours remains stable, 5-10 cases per year.
Palliativ therapy with 153Sm-EDTMP and 223Ra-diklorid (Xofigo) of patients with painful bone metastases is carried out about 200 times per year.

+36 (1) 224 8600
Skip to content